Neurobiology of adolescent substance use and addictive behaviors: Treatment implications

TY - JOUR

T1 - Neurobiology of adolescent substance use and addictive behaviors

T2 - Treatment implications

AU - Hammond, Christopher J.

AU - Mayes, Linda C.

AU - Potenza, Marc N.

N1 - Funding Information: *Corresponding author: christopher.hammond@yale.edu Funding Source: This research was supported in part by grants RL1 AA017539, R01 DA018647, and P20DA027844 from the National Institutes of Health, Bethesda, MD; the Connecticut State Department of Mental Health and Addiction Services, Hartford, CT; the Yale Center for Clinical Investigation, New Haven, CT; and a Center of Excellence in Gambling Research Award from the National Center for Responsible Gaming and its Institute for Research on Gambling Disorders. The funding agencies did not provide input or comment on the content of the manuscript, and the content of the manuscript reflects the contributions and thoughts of the authors and do not necessarily reflect the views of the funding agencies. Conflict of Interest and Financial Disclosures: The authors report no conflicts of interest with respect to the content of this article. Dr. Hammond has received support from the American Psychiatric Association Child & Adolescent Fellowship; an unrestricted education grant supported by Shire Pharmaceuticals; and the American Academy of Child & Adolescent Psychiatry Pilot Research Award for Junior Investigators supported by Lilly USA, LLC. Dr. Potenza has consulted for and advised Boehringer Ingelheim, Ironwood, and Lundbeck; has consulted for and had financial interests in Somaxon; has received research support from the National Institutes of Health, Veteran’s Administration, Mohegan Sun Casino, National Center for Responsible Gaming and its affiliated Institute for Research on Gambling Disorders, Forest Laboratories, Ortho-McNeil, Oy-Control/Biotie, Glaxo-SmithKline, and Psyadon Pharmaceuticals; has participated in surveys, mailings, and telephone consultations related to drug addiction, impulse control disorders, and other health topics; has consulted for law offices and the federal public defender’s office on issues related to impulse control disorders; provides clinical care in the Connecticut Department of Mental Health and Addiction Services Problem Gambling Services Program; has performed grant reviews for the National Institutes of Health and other agencies; has guest-edited journal sections; has given academic lectures in grand rounds, CME events, and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts. Dr. Mayes reports no disclosures. The authors alone are responsible for the content and writing of this manuscript. Contributor’s Statements: All authors have participated in the concept and design, analysis and interpretation of data, and drafting or revising of this article. Dr. Hammond conceptualized and designed the article, drafted the initial article, and approved the final article as submitted. Dr. Mayes conceptualized and designed the article, critically reviewed, edited, and revised drafts of this article, and approved the final article as submitted. Dr. Potenza conceptualized and designed the article, critically reviewed, edited, and revised drafts of this article, and approved the final article as submitted.

PY - 2014/4

Y1 - 2014/4

UR - http://www.scopus.com/inward/record.url?scp=84903216853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903216853&partnerID=8YFLogxK

M3 - Article

C2 - 25022184

AN - SCOPUS:84903216853

SN - 1934-4287

VL - 25

SP - 15

EP - 32

JO - Adolescent medicine: state of the art reviews

JF - Adolescent medicine: state of the art reviews

IS - 1

ER -